Utilization and Comparative Effectiveness of Caspofungin and Voriconazole Early after Market Approval in the US


Ascioglu S. , Chan K. A.

PLOS ONE, cilt.9, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives: Both caspofungin and voriconazole were initially approved by the FDA with very narrow indications. Our aim was to evaluate the utilization patterns and comparative effectiveness of these agents early after marketing before any labeling change occurred.